OBJECTIVES: The aim of this study was to evaluate the association between physical activity and changes in levels of highly sensitive troponin T (cTnT) and N-terminal pro-B-type natriuretic peptide (NT-proBNP), and the subsequent risk of the development of heart failure (HF) in community-dwelling older adults. BACKGROUND: Higher baseline levels of cTnT and NT-proBNP and increases over time correlate with the risk of HF in older adults. Factors modifying these levels have not been identified. METHODS: NT-proBNP and cTnT were measured at baseline and 2 to 3 years later in adults 65 years of age and older free of HF participating in the Cardiovascular Health Study. Self-reported physical activity and walking pace were combined into a composite score. An increase was prespecified for NT-proBNP as a >25% increment from baseline to ≥190 pg/ml and for cTnT as a >50% increment from baseline in participants with detectable levels (≥3 pg/ml). RESULTS: A total of 2,933 participants free of HF had NT-proBNP and cTnT measured at both time points. The probability of an increase in biomarker concentrations between baseline and follow-up visits was inversely related to the physical activity score. Compared with participants with the lowest score, those with the highest score had an odds ratio of 0.50 (95% confidence interval: 0.33 to 0.77) for an increase in NT-proBNP and an odds ratio of 0.30 (95% confidence interval: 0.16 to 0.55) for an increase in cTnT, after adjusting for comorbidities and baseline levels. A higher activity score associated with a lower long-term incidence of HF. Moreover, at each level of activity, an increase in either biomarker still identified those at higher risk. CONCLUSIONS: These findings suggest that moderate physical activity has protective effects on early heart failure phenotypes, preventing cardiac injury and neurohormonal activation.
OBJECTIVES: The aim of this study was to evaluate the association between physical activity and changes in levels of highly sensitive troponin T (cTnT) and N-terminal pro-B-type natriuretic peptide (NT-proBNP), and the subsequent risk of the development of heart failure (HF) in community-dwelling older adults. BACKGROUND: Higher baseline levels of cTnT and NT-proBNP and increases over time correlate with the risk of HF in older adults. Factors modifying these levels have not been identified. METHODS: NT-proBNP and cTnT were measured at baseline and 2 to 3 years later in adults 65 years of age and older free of HF participating in the Cardiovascular Health Study. Self-reported physical activity and walking pace were combined into a composite score. An increase was prespecified for NT-proBNP as a >25% increment from baseline to ≥190 pg/ml and for cTnT as a >50% increment from baseline in participants with detectable levels (≥3 pg/ml). RESULTS: A total of 2,933 participants free of HF had NT-proBNP and cTnT measured at both time points. The probability of an increase in biomarker concentrations between baseline and follow-up visits was inversely related to the physical activity score. Compared with participants with the lowest score, those with the highest score had an odds ratio of 0.50 (95% confidence interval: 0.33 to 0.77) for an increase in NT-proBNP and an odds ratio of 0.30 (95% confidence interval: 0.16 to 0.55) for an increase in cTnT, after adjusting for comorbidities and baseline levels. A higher activity score associated with a lower long-term incidence of HF. Moreover, at each level of activity, an increase in either biomarker still identified those at higher risk. CONCLUSIONS: These findings suggest that moderate physical activity has protective effects on early heart failure phenotypes, preventing cardiac injury and neurohormonal activation.
Authors: Peter Kokkinos; Jonathan Myers; Charles Faselis; Demosthenes B Panagiotakos; Michael Doumas; Andreas Pittaras; Athanasios Manolis; John Peter Kokkinos; Pamela Karasik; Michael Greenberg; Vasilios Papademetriou; Ross Fletcher Journal: Circulation Date: 2010-08-09 Impact factor: 29.690
Authors: Christopher R deFilippi; James A de Lemos; Robert H Christenson; John S Gottdiener; Willem J Kop; Min Zhan; Stephen L Seliger Journal: JAMA Date: 2010-11-15 Impact factor: 56.272
Authors: J Gustav Smith; Christopher Newton-Cheh; Peter Almgren; Joachim Struck; Nils G Morgenthaler; Andreas Bergmann; Pyotr G Platonov; Bo Hedblad; Gunnar Engström; Thomas J Wang; Olle Melander Journal: J Am Coll Cardiol Date: 2010-11-16 Impact factor: 24.094
Authors: Jacob Sattelmair; Jeremy Pertman; Eric L Ding; Harold W Kohl; William Haskell; I-Min Lee Journal: Circulation Date: 2011-08-01 Impact factor: 29.690
Authors: William S Weintraub; Stephen R Daniels; Lora E Burke; Barry A Franklin; David C Goff; Laura L Hayman; Donald Lloyd-Jones; Dilip K Pandey; Eduardo J Sanchez; Andrea Parsons Schram; Laurie P Whitsel Journal: Circulation Date: 2011-07-25 Impact factor: 29.690
Authors: Adeel Safdar; Jacqueline M Bourgeois; Daniel I Ogborn; Jonathan P Little; Bart P Hettinga; Mahmood Akhtar; James E Thompson; Simon Melov; Nicholas J Mocellin; Gregory C Kujoth; Tomas A Prolla; Mark A Tarnopolsky Journal: Proc Natl Acad Sci U S A Date: 2011-02-22 Impact factor: 11.205
Authors: James A de Lemos; Mark H Drazner; Torbjorn Omland; Colby R Ayers; Amit Khera; Anand Rohatgi; Ibrahim Hashim; Jarett D Berry; Sandeep R Das; David A Morrow; Darren K McGuire Journal: JAMA Date: 2010-12-08 Impact factor: 56.272
Authors: Justin T Saunders; Vijay Nambi; James A de Lemos; Lloyd E Chambless; Salim S Virani; Eric Boerwinkle; Ron C Hoogeveen; Xiaoxi Liu; Brad C Astor; Thomas H Mosley; Aaron R Folsom; Gerardo Heiss; Josef Coresh; Christie M Ballantyne Journal: Circulation Date: 2011-03-21 Impact factor: 29.690
Authors: Naoki Fujimoto; Anand Prasad; Jeffrey L Hastings; Armin Arbab-Zadeh; Paul S Bhella; Shigeki Shibata; Dean Palmer; Benjamin D Levine Journal: Circulation Date: 2010-10-18 Impact factor: 29.690
Authors: Stephen L Seliger; Susie N Hong; Robert H Christenson; Richard Kronmal; Lori B Daniels; Joao A C Lima; James A de Lemos; Alain Bertoni; Christopher R deFilippi Journal: Circulation Date: 2017-02-03 Impact factor: 29.690
Authors: Roberta Florido; Chiadi E Ndumele; Lucia Kwak; Yuanjie Pang; Kunihiro Matsushita; Jennifer A Schrack; Mariana Lazo; Vijay Nambi; Roger S Blumenthal; Aaron R Folsom; Josef Coresh; Christie M Ballantyne; Elizabeth Selvin Journal: JACC Heart Fail Date: 2017-05 Impact factor: 12.035
Authors: James A de Lemos; Colby R Ayers; Benjamin D Levine; Christopher R deFilippi; Thomas J Wang; W Gregory Hundley; Jarett D Berry; Stephen L Seliger; Darren K McGuire; Pamela Ouyang; Mark H Drazner; Matthew Budoff; Philip Greenland; Christie M Ballantyne; Amit Khera Journal: Circulation Date: 2017-03-30 Impact factor: 29.690
Authors: Kanan Patel; Xuemei Sui; Yan Zhang; Gregg C Fonarow; Inmaculada B Aban; Cynthia J Brown; Vera Bittner; Dalane W Kitzman; Richard M Allman; Maciej Banach; Wilbert S Aronow; Stefan D Anker; Steven N Blair; Ali Ahmed Journal: Int J Cardiol Date: 2013-02-04 Impact factor: 4.164
Authors: Tariq Ahmad; Mona Fiuzat; Daniel B Mark; Ben Neely; Megan Neely; William E Kraus; Dalane W Kitzman; David J Whellan; Mark Donahue; Faiez Zannad; Ileana L Piña; Kirkwood Adams; Christopher M O'Connor; G Michael Felker Journal: Am Heart J Date: 2013-11-04 Impact factor: 4.749
Authors: Pratyaksh K Srivastava; Aruna D Pradhan; Nancy R Cook; Paul M Ridker; Brendan M Everett Journal: Am J Cardiol Date: 2015-11-18 Impact factor: 2.778
Authors: Roberta Florido; Lucia Kwak; Mariana Lazo; Vijay Nambi; Haitham M Ahmed; Sheila M Hegde; Gary Gerstenblith; Roger S Blumenthal; Christie M Ballantyne; Elizabeth Selvin; Aaron R Folsom; Josef Coresh; Chiadi E Ndumele Journal: Circulation Date: 2018-01-31 Impact factor: 29.690
Authors: Josephine L Harrington; Colby Ayers; Jarett D Berry; Torbjørn Omland; Ambarish Pandey; Stephen L Seliger; Christie M Ballantyne; Jacquelyn Kulinski; Christopher R deFilippi; James A de Lemos Journal: Circulation Date: 2017-10-10 Impact factor: 29.690